![]() |
Name |
4-Hydroxyvertixanthone
|
Molecular Formula | C16H12O6 | |
IUPAC Name* |
methyl 3,8-dihydroxy-6-methyl-9-oxoxanthene-1-carboxylate
|
|
SMILES |
CC1=CC(=C2C(=C1)OC3=CC(=CC(=C3C2=O)C(=O)OC)O)O
|
|
InChI |
InChI=1S/C16H12O6/c1-7-3-10(18)14-11(4-7)22-12-6-8(17)5-9(16(20)21-2)13(12)15(14)19/h3-6,17-18H,1-2H3
|
|
InChIKey |
MJOGVUMPZLEYIH-UHFFFAOYSA-N
|
|
Synonyms |
4-Hydroxyvertixanthone; 85003-85-6; W4KJT6YJP8; methyl 3,8-dihydroxy-6-methyl-9-oxo-9H-xanthene-1-carboxylate; Methyl 1,6-dihydroxy-3-methylxanthone-8-carboxylate; methyl 3,8-dihydroxy-6-methyl-9-oxoxanthene-1-carboxylate; 9H-Xanthene-1-carboxylic acid, 3,8-dihydroxy-6-methyl-9-oxo-, methyl ester; starbld0013141; UNII-W4KJT6YJP8; MEGxm0_000397; CHEMBL4529229; ACon0_000932; CHEBI:68288; ZINC13335396; Q27136784; 3,8-Dihydroxy-6-methyl-9-oxo-9H-xanthene-1-carboxylic acid methyl ester; Methyl 3,8-dihydroxy-6-methyl-9-oxo-9H-xanthene-1-carboxylate_120100
|
|
CAS | 85003-85-6 | |
PubChem CID | 23786313 | |
ChEMBL ID | CHEMBL4529229 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 300.26 | ALogp: | 3.0 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 93.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 22 | QED Weighted: | 0.529 |
Caco-2 Permeability: | -4.864 | MDCK Permeability: | 0.00001310 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.915 |
Human Intestinal Absorption (HIA): | 0.03 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.917 |
Blood-Brain-Barrier Penetration (BBB): | 0.035 | Plasma Protein Binding (PPB): | 88.90% |
Volume Distribution (VD): | 0.747 | Fu: | 10.48% |
CYP1A2-inhibitor: | 0.971 | CYP1A2-substrate: | 0.907 |
CYP2C19-inhibitor: | 0.62 | CYP2C19-substrate: | 0.064 |
CYP2C9-inhibitor: | 0.776 | CYP2C9-substrate: | 0.925 |
CYP2D6-inhibitor: | 0.765 | CYP2D6-substrate: | 0.426 |
CYP3A4-inhibitor: | 0.467 | CYP3A4-substrate: | 0.099 |
Clearance (CL): | 3.931 | Half-life (T1/2): | 0.815 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.049 |
Drug-inuced Liver Injury (DILI): | 0.859 | AMES Toxicity: | 0.351 |
Rat Oral Acute Toxicity: | 0.017 | Maximum Recommended Daily Dose: | 0.885 |
Skin Sensitization: | 0.646 | Carcinogencity: | 0.018 |
Eye Corrosion: | 0.072 | Eye Irritation: | 0.963 |
Respiratory Toxicity: | 0.219 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003136 | ![]() |
0.783 | D0K8KX | ![]() |
0.395 | ||
ENC002690 | ![]() |
0.783 | D04AIT | ![]() |
0.388 | ||
ENC002106 | ![]() |
0.710 | D06GCK | ![]() |
0.330 | ||
ENC001749 | ![]() |
0.690 | D07MGA | ![]() |
0.301 | ||
ENC002523 | ![]() |
0.667 | D0G5UB | ![]() |
0.290 | ||
ENC001750 | ![]() |
0.643 | D0Y7PG | ![]() |
0.267 | ||
ENC005167 | ![]() |
0.641 | D0O6KE | ![]() |
0.248 | ||
ENC002197 | ![]() |
0.623 | D0H2ZW | ![]() |
0.247 | ||
ENC004289 | ![]() |
0.622 | D0FA2O | ![]() |
0.244 | ||
ENC003814 | ![]() |
0.603 | D06FVX | ![]() |
0.243 |